Engineers at the McKelvey School of Engineering at Washington University in St. Louis have received federal funding for a rapid COVID-19 test using a newly developed technology called plasmonic-fluor.
The test is based on a new biolabeling technology called plasmonic-fluor
Engineers at the McKelvey School of Engineering at Washington University in St. Louis have received federal funding for a rapid COVID-19 test using a newly developed technology.
Srikanth Singamaneni, professor of mechanical engineering and materials science, and his team have developed a rapid, highly sensitive and accurate biosensor based on an ultrabright fluorescent nanoprobe, which has the potential to be broadly deployed.
Called plasmonic-fluor, the ultrabright fluorescent nanoprobe can also help in resource-limited conditions because it requires fewer complex instruments to read the results. The National Science Foundation has awarded Singamaneni and his team a $100,008 grant toward developing a COVID-19 test using plasmonic-fluor.
Singamaneni hypothesizes their plasmonic-fluor-based biosensor will be 100 times more sensitive compared with the conventional SARS-CoV-2 antibody detection method. Increased sensitivity would allow clinicians and researchers to more easily find positive cases and lessen the chance of false negatives.
Plasmonic-fluor works by increasing the fluorescence signal to background noise. Imagine trying to catch fireflies outside on a sunny day. You might net one or two, but against the glare of the sun, those little buggers are difficult to see. What if those fireflies had the similar brightness as a high-powered flashlight?
Plasmonic-fluor effectively turns up the brightness of fluorescent labels used in a variety of biosensing and bioimaging methods. In addition to COVID-19 testing, it could potentially be used to diagnose, for instance, that a person has had a heart attack by measuring the levels of relevant molecules in blood or urine samples.
Using plasmonic-fluor, which is composed of gold nanoparticles coated with conventional dyes, researchers have been able to achieve up to a 6,700-fold brighter fluorescent nanolabel compared with conventional dyes, which can potentially lead to early diagnosis. Using this nanolabel as an ultrabright flashlight, they have demonstrated the detection of extremely small amounts of target biomolecules in biofluids and even molecules present on the cells.
The study was published in the April 20 issue of Nature Biomedical Engineering.
Gold nanoparticles serve as beacons
In biomedical research and clinical labs, fluorescence is used as a beacon to see and follow target biomolecules with precision. It’s an extremely useful tool, but it’s not perfect.
“The problem in fluorescence is, in a lot of cases, it’s not sufficiently intense,” Singamaneni said. If the fluorescent signal isn’t strong enough to stand out against background signals, just like fireflies against the glare of the sun, researchers may miss seeing something less abundant but important.
“Increasing the brightness of a nanolabel is extremely challenging,” said Jingyi Luan, lead author of the paper. But here, it’s the gold nanoparticle sitting at the center of the plasmonic-fluor that really does the work of efficiently turning the fireflies into flashlights, so to speak. The gold nanoparticle acts as an antenna, strongly absorbing and scattering light. That highly concentrated light is funneled into the fluorophore placed around the nanoparticle. In addition to concentering the light, the nanoparticles speed up the emission rate of the fluorophores. Taken together, these two effects increase the fluorescence emission.
Essentially, each fluorophore becomes a more efficient beacon, and the 200 fluorophores sitting around the nanoparticle emit a signal that is equal to 6,700 fluorophores.
In addition to detecting low quantities of molecules, sensing time can be shortened using plasmonic-fluor as brighter beacons mean fewer captured proteins are needed to determine their presence.
The researchers have also shown that plasmonic-fluor allows the detection of multiple proteins simultaneously. And in flow cytometry, plasmonic-fluor’s brightening effect allows for a more precise and sensitive measurement of proteins on cell surface, whose signal may have been buried in the background noise using traditional fluorescent tagging.
There have been other efforts to enhance fluorescent tagging in imaging, but many require the use of an entirely new workflow and measurement platform. In addition to plasmonic-fluor’s ability to greatly increase the sensitivity and decrease the sensing time, it doesn’t require any changes to existing laboratory tools or techniques.
The technology has been licensed to Auragent Bioscience LLC by Washington University’s Office of Technology Management. Auragent is in the process of further development and scaling up the production of plasmonic-fluors for commercialization.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Optical secret sharing with cascaded metasurface holographyon April 14, 2021 at 11:17 am
All holographic images were captured by projecting the Fourier space of the metasurface plane on a complementary metal oxide semiconductor (CMOS) camera (EO USB 2.0 CMOS) with the usage of a ...
- Immunomagnetic sequential ultrafiltration (iSUF) platform for enrichment and purification of extracellular vesicles from biofluidson April 13, 2021 at 2:18 am
Finally, EVs were stained with HER2-PE monoclonal antibody (#98710S, Cell Signaling Technology, Danvers, MA), CD24-Alexa Fluor 594 monoclonal antibody (#NB10077903AF594, Novus Biologicals), CD63 ...
- Photoactivated nanomotors via aggregation induced emission for enhanced phototherapyon April 6, 2021 at 2:44 am
The cells were stained with wheat germ agglutinin Alexa Fluor-TM 488 conjugate and Hoechst 33342 to show the cell membrane, as well as with propidium iodide (PI) to show the real-time enhanced ...
- Electro-plasmonic nanoantenna: A nonfluorescent optical probe for ultrasensitive label-free detection of electrophysiological signalson April 4, 2021 at 5:01 pm
Our electro-plasmonic nanoantennas with drastically enhanced cross sections (~10 4 nm 2 compared to typical values of ~10 −2 nm 2 for voltage-sensitive fluorescence dyes and ~1 nm 2 for quantum dots) ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Rapid COVID-19 test
- Euphoric clubbers hit dance floor again as Spain trials digital COVID-19 passon May 2, 2021 at 10:36 am
Mandatory face masks could not conceal their delight as clubbers in the Spanish city of Girona moved to the thumping beats of house music put on by a live DJ. For the first time in eight months, ...
- Sona to Commence Clinical Trial for COVID-19 Rapid Saliva Teston May 1, 2021 at 7:45 pm
Sona to Commence Clinical Trial for COVID-19 Rapid Saliva Test This news release constitutes a designated news release for the purposes of the Company's prospectus supplement dated April 9, 2021 to ...
- Half-hour hero: the lowdown on regular rapid Covid-19 testingon April 30, 2021 at 12:57 pm
CASES of coronavirus are continuing to fall nationwide, lockdown restrictions are easing and life is beginning to get moving again. However, even though more than half the country has now had ...
- RNA-extraction-free nano-amplified colorimetric test for point-of-care clinical diagnosis of COVID-19on April 30, 2021 at 11:27 am
This protocol provides an RNA extraction–free nano-amplified colorimetric test that enables rapid detection of SARS-CoV-2 with the naked eye. The test uses plasmonic gold nanoparticles capped with ...
- 5 things you didn't know about your rapid COVID-19 teston April 30, 2021 at 2:08 am
Did you know you can carry and transmit Covid-19 and not show symptoms? Since the outbreak of COVID-19, testing has been key in identifying positive cases to ensure that anyone carrying the virus can ...